Robert Graser, DPM
Foot Surgery · Boerne, TXNPI 1457300931
Payments from drug & device makers
What this record shows
This record is dominated by other: $51,260 of the $54,101 with a category attached, or 94.7%. Convatec Inc. accounts for 94.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $51,351 and has fallen 99.8% since, to $81 in 2025. Among foot surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $1865.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$51K
- Pylant Medical$2K
- Stryker$143
- Amgen$123
- Johnson & Johnson$76
- Treace Medical Concepts, Inc.$57
- plus $128 from 5 others
What the payments were for
- Food & beverage$5261%
- Education$2,3154%
- Other$51,26095%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 10 | $51,260 |
| Pylant Medical | 2 | $2,315 |
| Stryker | 1 | $143 |
| Amgen | 1 | $123 |
| Johnson & Johnson | 2 | $76 |
| Treace Medical Concepts, Inc. | 3 | $57 |
| Sebela Pharmaceuticals Inc. | 3 | $43 |
| Orthofix Medical, Inc. | 4 | $39 |
| Metric Medical Devices, Inc. | 1 | $20 |
| Triad Life Sciences Inc. | 1 | $13 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$51,260
- EASY CLIP$143
- ALLOWRAP$143
- KRYSTEXXA$123
How this compares
$54,101 in reported general payments places this provider in the 95th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 68 | $1,604 |
| Methylprednisolone | 58 | $1,223 |
| Pregabalin | 32 | $1,065 |
| Gabapentin | 66 | $1,041 |
| Terbinafine Hcl | 34 | $631 |
| Pentoxifylline | 11 | $450 |
| Paroxetine Hcl | 28 | $382 |
| Ketorolac Tromethamine | 13 | $176 |
| Cephalexin | 36 | $173 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Boerne
- Marque AllenSan Antonio$204K
- James JacobsKaty$81K
- Lawrence LaverySan Antonio$59K
- Richard KehSan Antonio$17K
- Chad ClauseWebster$17K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Fernando CruzCorsicana$12K
- Richard GalperinDallas$12K
- Terry WrightArlington$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.